Y
Live / Registered — Registered (as of 04 Aug 2026)
What this means for you
Registered since 04 Aug 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Aug 2032: the §8 declaration of use).
Record
- Serial number
- 97126771
- Registration number
- 8380410
- Mark type
- Design + words
- Filed
- 16 Nov 2021
- Published for opposition
- 20 Jun 2023
- Registered
- 04 Aug 2026
- Next maintenance filing
- §8 declaration of use, due by 04 Aug 2032 (grace period to 04 Feb 2033)
- Attorney of record
- John P. Rynkiewicz
Goods and services
- Class 042 — Scientific and technological services: Implementation of early assessment in new drug development fields to develop pharmaceutical preparations and medicines; scientific research and development; product quality testing; drug evaluation, in the nature of product quality evaluation, namely, drug discovery evaluation, drug developablity, drug efficacy, and drug metabolic kinetics for various biological or chemical therapeutics for oncology, immunology, infectious and metabolic diseases; pharmaceutical research services; biological research and analysis; technical research in the field of oncology, immunology, infectious and metabolic diseases; chemical research and analysis; bacteriological research and analysis; scientific research in the nature of conducting clinical trials for others; product research and development; scientific laboratory services
- Class 044 — Medical, beauty and agricultural services: Providing medical information in the field of pharmaceutical products, medicines, vaccines, healthcare, health issues, health awareness and treatment options; On-line information services, namely, providing health information to physicians, healthcare professionals and patients on the topics of health issues, pharmaceutical products and treatments; Providing medical information via a website; providing a website featuring medical information for oncology, immunology, infectious and metabolic diseases
Owner
- TopAlliance Biosciences Inc., Menlo Park, CA, US
- TopAlliance Biosciences Inc., Menlo Park, CA, US
- TopAlliance Biosciences Inc., Menlo Park, CA, US
Prosecution history
- 04 Aug 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Aug 2026 — REGISTERED-PRINCIPAL REGISTER
- 13 Jul 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Jul 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jun 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Feb 2026 — USE AMENDMENT FILED
- 24 Jun 2026 — SOU EXTENSION 5 GRANTED
- 11 Feb 2026 — SOU EXTENSION 5 FILED
- 24 Jun 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Feb 2026 — TEAS STATEMENT OF USE RECEIVED
- 13 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2025 — SOU EXTENSION 4 GRANTED
- 12 Aug 2025 — SOU EXTENSION 4 FILED